First Defiance Finl (FDEF) 39.66 $FDEF New Strong Buy

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Defiance Finl (FDEF) 39.66 $FDEF

New Strong Buy Stocks for May 19th
Swarup Gupta - Zacks Investment Research - Thu May 19, 7:34AM CDT
5 fresh stock additions to the Zacks Rank #1 (Strong Buy) List for Thursday
HAS: 86.01 (+0.14), DISCB: 26.50 (+0.09), FDEF: 39.66 (+0.41), GIB: 46.10 (+0.32), EXTR: 3.59 (+0.06)

How First Defiance Financial (FDEF) Stock Stands Out in a Strong Industry
Zacks Equity Research - Zacks Investment Research - Wed May 18, 7:55AM CDT
First Defiance Financial (FDEF) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. Announces Election of Thomas A. Reineke to Its Board of Directors
BusinessWire - Tue May 03, 5:00PM CDT
First Defiance Financial Corp. (NASDAQ: FDEF), the holding company for First Federal Bank of the Midwest and First Insurance Group, today announced that Thomas A. Reineke was elected to the Company's Board of Directors during its Annual Meeting of Shareholders held on April 19, filling the seat left vacant by the retirement of Peter A. Diehl. Currently, Reineke is President and CEO of Reineke Family Dealerships.
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. Announces 2016 First Quarter Earnings
BusinessWire - Mon Apr 18, 4:30PM CDT
--Net income of $7.1 million for 2016 first quarter compared to $6.6 million in the first quarter of 2015
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. to Release First Quarter Earnings on April 18 and Host Conference Call and Webcast on April 19
BusinessWire - Thu Mar 17, 2:00PM CDT
First Defiance Financial Corp. (NASDAQ: FDEF) announced today that it intends to report first quarter results on Monday, April 18, 2016 after the close of the market. The earnings news release will be available on the company's investor relations website at www.fdef.com and at major financial information sites.
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. Announces Share Repurchase Program
BusinessWire - Fri Jan 29, 7:00AM CST
First Defiance Financial Corp. (NASDAQ: FDEF) announced today that its Board of Directors decided it is in the best interest of the Company and its shareholders to institute a new share repurchase program of up to 5%, or approximately 450,000 shares, of the common stock outstanding. Repurchases will be made periodically depending on market conditions and other factors. The repurchased shares will be held as treasury stock and will be available for general corporate purposes, including employee stock option plans. The exact number of shares to be repurchased by the company is not guaranteed.
FDEF: 39.66 (+0.41)

First Defiance Financial reports stable net income year-on-year
M2 - Tue Jan 19, 4:05AM CST
First Defiance Financial Corp (NASDAQ:FDEF) reported on Monday that it recorded net earnings of USD6.6m or USD0.71 per diluted common share for the fourth quarter of 2015, stable compared to to the net earnings of USD6.4m or USD0.65 per diluted common share for the fourth quarter of 2014.
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. Reports Record Full Year Earnings of $2.82 Per Share for 2015, Up 15.6% from Full Year 2014
BusinessWire - Mon Jan 18, 5:16PM CST
--Net income of $6.6 million for 2015 fourth quarter compared to $6.4 million in the fourth quarter of 2014
FDEF: 39.66 (+0.41)

First Defiance beats 4Q profit forecasts
Automated Insights - Mon Jan 18, 4:45PM CST
DEFIANCE, Ohio (AP) _ First Defiance Financial Corp. (FDEF) on Monday reported fourth-quarter earnings of $6.6 million.
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. to Release Fourth Quarter Earnings on January 18 and Host Conference Call and Webcast on January 19
BusinessWire - Fri Dec 18, 8:18AM CST
First Defiance Financial Corp. (NASDAQ: FDEF) announced today that it intends to report fourth quarter and year-end results on Monday, January 18, 2016 after the close of the market. The earnings news release will be available on the company's investor relations website at www.fdef.com and at major financial information sites.
FDEF: 39.66 (+0.41)

3 Reasons Momentum Stock Investors Will Love First Defiance Financial (FDEF)
Zacks Equity Research - Zacks Investment Research - Wed Oct 28, 7:32AM CDT
First Defiance Financial is an impressive stock as it has a strong Momentum Score, favorable Zacks Rank and is also seeing positive estimate revisions
FDEF: 39.66 (+0.41)

First Defiance Financial reports lower net income for Q3 2015 compared to 2014
M2 - Tue Oct 20, 4:15AM CDT
First Defiance Financial Corp (NASDAQ:FDEF) reported on Monday for the third quarter ended 30 September 2015 a total net income of USD6.7m or USD0.72 per diluted common share, decreased compared to the net income of USD7.1m or USD0.71 per diluted common share for the third quarter of 2014.
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. Announces 2015 Third Quarter Earnings
BusinessWire - Mon Oct 19, 4:30PM CDT
--Net income of $6.7 million for 2015 third quarter compared to $7.1 million in the 2014 third quarter
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. to Release Third Quarter Earnings on October 19 and Host Conference Call and Webcast on October 20
BusinessWire - Thu Sep 24, 11:35AM CDT
First Defiance Financial Corp. (NASDAQ: FDEF) announced today that it intends to report third quarter results on Monday, October 19, 2015 after the close of the market. The earnings news release will be available on the company's investor relations website at www.fdef.com and at major financial information sites.
FDEF: 39.66 (+0.41)

Is First Defiance Financial (FDEF) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 31, 7:58AM CDT
First Defiance Financial in the Financial-Savings & Loans space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
FDEF: 39.66 (+0.41)

Looking for a Top Value Stock? 3 Reasons Why First Defiance Financial (FDEF) is an Excellent Choice - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 7:42AM CDT
First Defiance Financial is a pretty good value pick and has been seeing solid activity on the earnings estimate front as well
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. Announces 2015 Second Quarter Earnings
BusinessWire - Mon Jul 20, 4:30PM CDT
--Net income of $6.6 million for 2015 second quarter up from $5.7 million in the 2014 second quarter
FDEF: 39.66 (+0.41)

First Defiance Financial Corp. to Present at Annual Keefe, Bruyette & Woods Community Bank Investor Conference
BusinessWire - Tue Jul 14, 10:00AM CDT
First Defiance Financial Corp. (NASDAQ: FDEF) announced today that Donald P. Hileman, President and CEO, and Kevin T. Thompson, Executive Vice President and CFO, will present at the Keefe, Bruyette & Woods (KBW) 16th Annual Community Bank Investor Conference on Tuesday, July 28, 2015 at 10:30 a.m. EDT. The presentation will be available as a webcast.
FDEF: 39.66 (+0.41)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

FuboTV Prepares for Q3 2024 Financial Results Release

Updated Category News Views 101

FuboTV to Reveal Q3 2024 Financial Insights FuboTV Inc. (d/b/a Fubo) (NYSE: FUBO), a prominent player in the sports streaming arena, has announced a significant event on the horizon. They will release their third quarter financial results for 2024 early in the market day, a move that provides a valuable update for investors and followers alike. Details about the Financial...

Continue Reading
Coinbase's Gokul Rajaram's Share Sale Highlights Market Trends

Updated Category News Views 262

Gokul Rajaram of Coinbase Sells Shares Recently, Gokul Rajaram, a director at Coinbase Global, Inc. (NASDAQ:COIN), made headlines by selling shares worth $64,536. This transaction took place in September, when he sold 400 shares at a price of $161.34 each. Such moves often attract a lot of attention from those tracking the cryptocurrency market and its developments...

Continue Reading
Robinhood's New Fund Unlocks Private AI Investments for All

Updated Category News Views 200

Robinhood Ventures' Bold Move Into Private AI Investments Robinhood Markets Inc. (NASDAQ: HOOD) is set to revolutionize the investment landscape by giving retail investors access to private startups focused on artificial intelligence (AI). Despite widespread chatter about a potential bubble in the AI sector, the company is moving forward with this innovative approach....

Continue Reading
IRG, PREP, and DWREP Join Forces for Major Site Redevelopment

Updated Category News Views 184

Investment in Future Growth In an exciting development, Industrial Realty Group, LLC (IRG), along with Provider Real Estate Partners (PREP) and DW Real Estate Partners, LLC (DWREP), have embarked on a significant project to redevelop an industrial property in Ohio. The trio has successfully acquired the Hilliard Commerce Center, a sprawling 177,680 square-foot facility...

Continue Reading
Understanding Publicis Groupe’s Recent Share Trading Activity

Updated Category News Views 149

Overview of Share Trading Activities Publicis Groupe recently engaged in notable share trading activities, reflecting its strategic moves in the market. This trading involves shares acquired as part of a pre-approved program by the company's shareholders, aimed at enhancing its capital management. Transaction Details During the latest trading window, Publicis Groupe...

Continue Reading